A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer

Clinical trial NCT00281632 · COMPLETED

Trial details

NCT number: NCT00281632
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Peritoneal Cancer Ovarian Cancer Neoplasms, Ovarian Fallopian Tube Cancer

Start date: 2006-03-01
Primary completion: 2008-04-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.